This paper investigated the potential effect of vortexing specimens on the detection of SARS-CoV-2, the virus that causes the novel 2019 coronavirus disease (COVID, COVID-19, COVID19), in nasopharyngeal and throat swabs using eight different assays.
Effect of not vortexing nasopharyngeal and throat swabs on SARS-CoV-2 nucleic acid detection: A pilot study.
Kanji JN, Pabbaraju K, Wong A, Beitku C, Deo A, Kailey S, Ma R, Tipples G, Zelyas N
Purpose
Conclusion
SARS-CoV-2 detection was 100% concordant between matched vortexed specimens (both types) analyzed using the E gene LDT assay and non-vortexed specimens when detection was with any of the other assays. Concordance for SARS-CoV-2 detection between vortex and non-vortexed specimens was 97.1% when both specimens were analyzed using the Roche Cobas assay, but when the vortexed specimen was analyzed by a different assay concordance ranged between 94.3% (Simplexa assay) and 100% (BioFire, Panther). Two of the three discordant results were blamed on freeze-thaw cycling since reanalysis using a frozen aliquot of the vortexed specimen yielded the same result as the non-vortexed specimen. CT values for the E gene LDT assay and β-2-microglobulin (B2M) were significantly higher in non-vortexed than vortexed specimens (mean difference of 0.09 cycles, P<0.0001 and 2.5 cycles, P<0.0001), but no difference in CT values were observed for either of the two genes with the Roche Cobas assay.
Studies (1)
Purpose
This study investigated the potential effect of vortexing specimens on the detection of SARS-CoV-2 in nasopharyngeal and throat swabs using eight different assays. One aliquot from each of 193 nasopharyngeal and 84 throat swab specimens in viral transport media was removed and immediately frozen at -70°C for up to 40 h. The remaining specimen was vortexed for 5-7 sec and allowed to settle for 5-15 min before analysis of aliquots; the rest of the vortexed specimen was frozen at -70°C and used when necessary for validation. Matched vortex and non-vortexed specimens were analyzed for SAR2-CoV-2 in the same batch using the SARS-CoV-2 envelope (E) gene LDT assay (219 pairs) or the Roche Cobas SARS-CoV-2 test (58 pairs), or individually with the BioFire (30 specimens), Panther (30 specimens), Simplexa (30 specimens), Xpress SARS-CoV-2 (34 specimens), or Xpress SARS-CoV-2/Flu/RSV (324 specimens) assays. Human RNA was detected by real-time RT-PCR amplification of β-2-microglobulin.
Summary of Findings
SARS-CoV-2 detection was 100% concordant between matched vortexed specimens analyzed using the E gene LDT assay and non-vortexed specimens when detection was with any of the other assays. Concordance for SARS-CoV-2 detection between vortex and non-vortexed specimens was 97.1% for the 58 specimens when both speiimens were analyzed using the Roche Cobas assay, but when the vortexed specimen was analyzed by a different assay concordance ranged between 94.3% (Simplexa assay) and 100% (BioFire and Panther). Two of the three discordant results were blamed on freeze-thaw cycling since an additional vortexed specimen yielded the same result as the non-vortexed specimen and produced higher CT values. CT values for the E gene LDT assay and B2M were significantly higher in non-vortexed than vortexed specimens (mean difference 0.09 cycles, P<0.0001 and 2.5 cycles, P<0.0001), but no difference in CT values were observed for either of the two genes with the Roche Cobas assay.
Biospecimens
CellNasal cavityCellOral CavityPreservation Types
FrozenNone (Fresh)Diagnoses
Pneumonia/Respiratory InfectionPlatforms
RNAReal-time qRT-PCRPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Aliquots and Components Biospecimen mixing Not vortexedVortexedStorage Freeze/thaw cycling 0 cycles1 cycleReal-time qRT-PCR Specific Targeted nucleic acid B2MBioFire assayPanther assayRoche Cobas SARS-CoV-2 assaySARS-CoV-2 envelope (E) gene LDT assaySimplexa assayXpress SARS-CoV-2 assayXpress SARS-CoV-2/Flu/RSV assay